IJGC Podcast

IJGC Podcast

Download on the App Store

IJGC Podcast episodes

  • Ovarian Cancer: A Patient’s Perspective with Gabriela Benjamin
    In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Gabriela Benjamin to discuss a patient’s perspective on ovarian cancer. Gabriela Gesteira Benjamin 38 years old and was born in Brazil and grew up in Miami. She attended Columbia University where she studied engineering. She has worked in finance for the past 15 years and is currently a portfolio manager at Blackrock. She is the daughter of Roberto Benjamin and late Fatima Gesteira and sister to Joana Benjamin and Dr. Carolina Benjamin and proud aunt of Nico and Enzo. Gabi has a zest for life, practicing tennis, yoga, pilates, meditation, Freediving and kitesurfing just to name a few. She was diagnosed with advance stage ovarian cancer one year ago, underwent chemotherapy and hysterectomy. She is currently in remission but remains on maintenance medication.
    Interviewee Info: Gabriela Benjamin (@galebaweBenjam)
    Highlights:
    - It benefits patients when doctors put themselves in the patient’s shoes and acknowledge how painful and difficult a cancer diagnosis is
    - Treatment is not an easy journey, but staying positive and continuing to live life help in the process and often the outcome.
    - You must learn to see the collateral beauty or the silver linings, whether it is the love you receive, nature or a breath you take when you feel good. This diagnosis will give you new lenses to view life with

    - The choice of what center you do care in and with what Doctor makes the difference. Do your research, It is a personal choice but a very important one. For me it was a combination of experience and affinity, and I could not be happier with my choice of Dr. Ramirez and MdAnderson.

    35 min
  • HPV-independent Cervical Cancers with Andreina Fernandes
    In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Andreina Fernandes to discuss HPV-independent Cervical Cancers. Dr. Fernandes is a Molecular Biologist, Doctor of Science, and author of “Human papillomavirus-independent cervical cancer,” the Lead Article for the January 2022 issue of IJGC. Dr. Fernandes is a Researcher of the Molecular Genetics Laboratory at the Institute of Oncology and Hematology, and Professor of the Faculty of Dentistry, at Universidad Central de Venezuela in Caracas, Venezuela.
    (https://ijgc.bmj.com/content/early/2021/12/08/ijgc-2021-003014)
    Highlights:
    -The percentage of HPV-independent tumors is very variable, around 5 and 10%.
    -HPV-independent tumors are characterized by a differentiated molecular profile with lower proliferative activity, a p53 immunostaining, and alterations in PTEN, p53, KRAS, CTNNB1, ARID1A and ARID5B.
    -Most HPV-independent tumors are adenocarcinomas, however, there have been reports of HPV-independent cases with squamous histology.
    -HPV-independent tumors are associated with early lymph node involvement, accelerated tumor growth, distant metastasis, and a more aggressive biological behavior, related to a worse disease free survival and overall survival.
    -The hit and run mechanism could explain the absence of the viral genome in the HPV-independent cervical cancer cases.

    Andreina Fernandes (@AndreFernandes2)

    30 min
  • Best of 2021: SENTOR Study: SLN in High-Risk Endometrial Cancer with Sarah Ferguson

    In this rebroadcasted episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Sarah Ferguson. Dr. Ferguson is a Professor in the Division of Gynecologic Oncology in the Department of Obstetrics and Gynecology at the University of Toronto and a member of the Division of Gynecologic Oncology at University Health Network/Sinai Health Systems. She is the Director of Research for the Division of Gynecologic Oncology at Princess Margaret Cancer. Dr. Ferguson completed her residency in Obstetrics and Gynecology at University of Toronto and a fellowship at Memorial Sloan-Kettering Cancer Centre in Gynecologic Oncology. Current research program includes prospective surgical trials in cervical and endometrial cancer, evaluation of patient reported outcomes and molecular characterization of endometrial cancer.

    30 min
  • Best of 2021: ESGO Guidelines on Perioperative Management Ovarian Cancer with Christina Fotopoulou

    In this rebroadcasted episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Professor Christina Fotopoulou to discuss the ESGO Guidelines on Perioperative Management Ovarian Cancer. Professor Fotopoulou is the lead author of “European Society of Gynaecological Oncology guidelines for the peri-operative management of patients with ovarian cancer,” which is the Lead Article of IJGC’s September 2021 issue. Professor Fotopoulou works at the Department of Surgery and Cancer at Imperial College London, UK. She is an elected ESGO council member and Chair of the ESGO guidelines committee.

    50 min
  • Combined metformin and progestin in endometrial cancer with Jennifer Chae-Kim
    In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Jennifer Chae-Kim. Dr. Chae-Kim is the author of Outcomes of women treated with progestin and metformin for atypical endometrial hyperplasia and early endometrial cancer: a systematic review and meta-analysis, which is the Lead Article of IJGC’s December 2021 issue. Dr. Chae-Kim is in her last year of OB/GYN residency at BSW-Temple, and will be pursuing her interests in fertility preservation and fellowship training in REI at the NIH next year.
    https://ijgc.bmj.com/content/early/2021/11/15/ijgc-2021-002699
    Jennifer Chae-Kim (@chae_md)
    Highlights
    1) Endometrial cancer and atypical endometrial hyperplasia are being diagnosed more frequently in reproductive-aged women, who may desire fertility-sparing therapy.
    2) Women who received progestin and metformin therapy were found to have lower disease relapse rates than those who received progestin alone.
    3) Combined therapy was not associated with significantly different rates of disease remission, pregnancy, live birth.

    4) Further research is needed to determine the parameters of clinical application of metformin to progestin therapy.

    29 min

About IJGC Podcast

From the publisher's feed

The International Journal of Gynecological Cancer (IJGC) podcast explores the latest research on detection, prevention, diagnosis, and treatment of gynecologic malignancies. Enjoy interviews with leading experts as they discuss novel and relevant topics in the field of gynecologic cancer.

More shows like IJGC Podcast

Medicine and Science from The BMJ by The BMJ

Medicine and Science from The BMJ

36 Listeners

BJSM Podcast by BMJ Group

BJSM Podcast

47 Listeners

DTB Podcast by BMJ Group

DTB Podcast

4 Listeners

Gut Podcast by BMJ Group

Gut Podcast

7 Listeners

Sharp Scratch by The BMJ

Sharp Scratch

5 Listeners

ADC Podcast by BMJ Group

ADC Podcast

3 Listeners

Thorax Podcast by BMJ Group

Thorax Podcast

4 Listeners

STI Podcast by BMJ Group

STI Podcast

3 Listeners

JNNP Podcast by BMJ Group

JNNP Podcast

9 Listeners

Heart Podcast by BMJ Group

Heart Podcast

40 Listeners

JNIS Podcast by BMJ Group

JNIS Podcast

14 Listeners

EBN Podcast by BMJ Group

EBN Podcast

1 Listeners

Practical Neurology Podcast by BMJ Group

Practical Neurology Podcast

51 Listeners

FG Podcast by BMJ Group

FG Podcast

0 Listeners

Medical Humanities Podcast by BMJ Group

Medical Humanities Podcast

6 Listeners

Lupus Science and Medicine Podcast by BMJ Group

Lupus Science and Medicine Podcast

15 Listeners

RMD Open Podcast by BMJ Group

RMD Open Podcast

3 Listeners

BMJ Best Practice Podcast by BMJ Group

BMJ Best Practice Podcast

28 Listeners

BMJ Future Health Podcast by BMJ Publishing Group

BMJ Future Health Podcast

0 Listeners